TUBA1/3/4 (Phospho-Tyr272) Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-TUBA1/3/4 (Phospho-Tyr272) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityTUBA1/3/4 (Phospho-Tyr272)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse, rat
Isotypen/a
Formatepitope affinity purified
Size0.05 mL, 0.1 mL
Concentration1.0 mg/ml
ApplicationsWestern Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThe antibody detects endogenous levels of TUBA1/3/4 only when phosphorylated at tyrosine 272. Microtubules of the eukaryotic cytoskeleton perform essential and diverse functions and are composed of a heterodimer of alpha and beta tubulins. The genes encoding these microtubule constituents belong to the tubulin superfamily, which is composed of six distinct families. Genes from the alpha, beta and gamma tubulin families are found in all eukaryotes. The alpha and beta tubulins represent the major components of microtubules, while gamma tubulin plays a critical role in the nucleation of microtubule assembly. There are multiple alpha and beta tubulin genes, which are highly conserved among species. Adler A.J., Bioorg. Med. Chem. 9:1967-1976(200
ImmunogenImmunogen Type: Peptide-KLH Immunogen Description: Peptide sequence around phosphorylation site of tyrosine 272 (A-T-Y(p)-A-P) derived from Human TUBA1/3/4.
Other Names[TBA1; TBA1A; TBA4A; TUBA1]
Gene, Accession #[TUBA1/3/4], Gene ID: 7846, NCBI: NP_001257328.1, UniProt: Q71U36
Catalog #MBS9401158
Price$200, $255
Order / More InfoTUBA1/3/4 (Phospho-Tyr272) Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.